Advances in Clinical Chemistry

The ACC series examines physiologic and pathophysiologic biochemistry and impact thereof on Clinical Chemistry testing and design. Molecular mechanisms of disease processes are highlighted in the context of traditional, current and emerging technologies. Advances in the development of improved diagnostic and predictive biomarkers are examined especially those targeting early and emerging diseases. These evolving technologies and analytic strategies have become increasing relevant given the healthcare and socioeconomic impact worldwide.